Mechanistic Physiologically Based Pharmacokinetic Modeling of the Dissolution and Food Effect of a Biopharmaceutics Classification System IV Compound—The Venetoclax Story-Reference-Cited by-同舟云学术

Mechanistic Physiologically Based Pharmacokinetic Modeling of the Dissolution and Food Effect of a Biopharmaceutics Classification System IV Compound—The Venetoclax Story

Published:2018-01 Issue:1 Volume:107 Page:495-502
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Emami Riedmaier Arian,Lindley David J.,Hall Jeffrey A.,Castleberry Steven,Slade Russell T.,Stuart Patricia,Carr Robert A.,Borchardt Thomas B.,Bow Daniel A.J.,Nijsen Marjoleen

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference41 articles.

1. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets;Souers;Nat Med,2013

2. Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia;Roberts;N Engl J Med,2016

3. Phase I first-in-human study of venetoclax in patients with relapsed or refractory non-Hodgkin lymphoma;Davids;J Clin Oncol,2017

4. Evaluation of Rifampin's transporter inhibitory and CYP3A inductive effects on the pharmacokinetics of venetoclax, a BCL-2 inhibitor: results of a single- and multiple-dose study;Agarwal;J Clin Pharmacol,2016

5. Effect of ketoconazole, a strong CYP3A inhibitor, on the pharmacokinetics of venetoclax, a BCL-2 inhibitor, in patients with non-Hodgkin lymphoma;Agarwal;Br J Clin Pharmacol,2017

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amorphous Solubility Advantage: Theoretical Considerations, Experimental Methods, and Contemporary Relevance;Journal of Pharmaceutical Sciences;2024-09

2. Integrating Dynamic in vitro Systems and Mechanistic Absorption Modeling: Case Study of Pralsetinib;Journal of Pharmaceutical Sciences;2024-09

3. Hydrophobic deep eutectic solvent (HDES) as oil phase in lipid-based drug formulations;International Journal of Pharmaceutics;2024-08

4. Cell selective BCL-2 inhibition enabled by lipid nanoparticles alleviates lung fibrosis;Journal of Controlled Release;2024-06

5. Evaluating Utilization of Tiny-TIM to Assess the Effect of Food on the Absorptions of Oral Drugs and Its Application on Biopharmaceutical Modeling;Journal of Pharmaceutical Sciences;2024-06